Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Declining bone density during osteoporosis treatment does not always mean the therapy has failed, and several factors must be ruled out first, including missed doses, poor absorption, low vitamin D or calcium, and hidden causes like thyroid problems, celiac disease, or steroid use. Next steps usually involve confirming the scan was done on the same machine, repeating labs, reviewing adherence, and then considering a switch from an oral bisphosphonate to an injectable, anabolic, or monoclonal antibody option. Timing matters too, since small changes can fall within scan error margins while true loss plus a new fracture signals a more urgent change in plan. There are important details and exceptions to weigh, so see below to understand more before assuming your medication stopped working. If you are noticing new back pain, height loss, or other worrying changes alongside falling scores, a free, instant, online symptom check can help you organize your symptoms and risk factors in minutes so your next conversation with a clinician is faster, clearer, and focused on the right tests.
Last reviewed for medical accuracy: 08/18/2026
Bone Density Falling on Treatment: Next Steps
It can be unsettling to learn that your bone density is decreasing despite treatment. You’re not alone—many people face this challenge. The good news is that there are clear steps you and your doctor can take to find out why your bones aren’t responding as expected and how to turn things around.
Why Bone Density May Keep Dropping Understanding potential reasons can help guide your next steps:
• Medication issues
– Missed doses, improper timing or incorrect storage can reduce effectiveness.
– Some osteoporosis drugs require precise scheduling (e.g., taking bisphosphonates on an empty stomach and remaining upright for 30–60 minutes).
• Inadequate dosing or choice of therapy
– You might need a higher dose or a different class of medication (antiresorptive vs. anabolic).
– Sometimes switching from a bisphosphonate to denosumab or adding teriparatide is necessary.
• Secondary causes of bone loss
– Uncontrolled thyroid disease, hyperparathyroidism or Cushing’s syndrome can accelerate bone breakdown.
– Malabsorption (celiac disease, inflammatory bowel disease) limits calcium and vitamin D absorption.
– Certain medications (steroids, some anti-seizure drugs) can weaken bone over time.
• Nutritional gaps
– Low calcium intake (dairy, fortified non-dairy milk, leafy greens).
– Vitamin D deficiency is very common and may blunt treatment response.
• Lifestyle factors
– Smoking and excessive alcohol interfere with bone remodeling.
– Lack of regular weight-bearing exercise deprives bone of the mechanical stress it needs to stay strong.
Diagnostic Steps to Consider If bone density is decreasing despite treatment, your doctor may recommend:
Medication review
– Confirm you’re taking each dose correctly.
– Check pharmacy refill history to ensure you haven’t missed doses.
Laboratory tests
• Calcium, phosphorus and magnesium
• 25-hydroxy vitamin D level
• Parathyroid hormone (PTH)
• Thyroid-stimulating hormone (TSH)
• Markers of bone turnover (CTX, P1NP)
• Celiac serologies or inflammation markers if absorption is suspect
Imaging updates
– Repeat your DXA (dual-energy X-ray absorptiometry) scan under standardized conditions (same machine, technician and lab for consistency).
– Consider advanced assessments like trabecular bone score (TBS) to evaluate bone microarchitecture.
Evaluation for secondary osteoporosis
– Endocrinologist consultation if hormonal causes are suspected.
– Gastroenterologist referral if you have digestive symptoms or malabsorption risk.
Adjusting Your Treatment Plan Based on diagnostic findings, your care team might:
• Optimize calcium and vitamin D
– Aim for 1,000–1,200 mg of elemental calcium daily (diet + supplements).
– Target a 25-hydroxy vitamin D level of at least 30 ng/mL.
• Change or add medications
– Switch to a different antiresorptive (e.g., from oral bisphosphonate to denosumab).
– Introduce an anabolic agent (teriparatide or abaloparatide) if bone density continues to fall.
– Use a sequential approach—start with an anabolic drug, then transition to an antiresorptive to maintain gains.
• Consider drug holidays carefully
– If you’ve been on a bisphosphonate for 5–10 years with stable bones, a short break may be advised.
– Each holiday should be monitored—resuming therapy if bone density drops again.
• Address secondary causes
– Treat overactive parathyroid glands or uncontrolled thyroid disease.
– Improve nutrient absorption in celiac disease or IBD with diet changes and medications.
Lifestyle Strategies to Support Bone Health Even the best medications work better when you adopt bone-friendly habits:
• Exercise regularly
– Weight-bearing activities like walking, hiking, dancing or jogging.
– Resistance training (light weights, resistance bands) 2–3 times per week.
– Balance and flexibility work (tai chi, yoga) to reduce fall risk.
• Nutrition focus
– Eat a variety of calcium-rich foods: low-fat dairy, fortified plant milks, kale, broccoli.
– Include lean protein, whole grains, fruits and vegetables for overall health.
– Limit caffeine and sodas, which may interfere with calcium absorption.
• Lifestyle modifications
– Quit smoking—tobacco use decreases bone formation.
– Keep alcohol to moderate levels (no more than 1 drink/day for women, 2 for men).
– Review home safety (clear tripping hazards, install grab bars) to prevent falls.
Monitoring Progress After making changes, ongoing monitoring is key:
• Repeat DXA every 1–2 years
– Track whether density is stabilizing or improving.
• Measure bone turnover markers
– Early indicator of how well treatment is working (can change before DXA results).
• Regular lab checks
– Ensure calcium, vitamin D and other labs remain in target ranges.
• Symptom tracking
– New pain, fractures or height loss require prompt attention.
– Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to explore new concerns.
When to Seek Immediate Help While most steps are planned over months, certain signs require urgent care:
• Sudden, severe back or bone pain (possible fracture)
• Acute muscle weakness or confusion (could reflect severe electrolyte imbalance)
• Signs of serious side effects from medications (e.g., jaw pain, vision changes, extreme fatigue)
Speak to a doctor right away about anything that could be life threatening or serious.
Final Thoughts Facing a decline in bone density despite treatment can feel discouraging. However, by:
• Investigating secondary causes
• Ensuring proper medication use
• Optimizing nutrition and lifestyle
• Monitoring closely with labs and scans
you and your healthcare team can often identify the barriers to success and create a more effective plan. Stay proactive, ask questions, and lean on your medical providers for guidance. Bone health is a long-term journey—small changes now can make a big difference in preventing fractures and preserving your quality of life.
(References)
* Geurs NC, Lewis CE, Jeffcoat MK. Osteoporosis and periodontal disease progression. Periodontol 2000. 2003;32:105-10. doi: 10.1046/j.0906-6713.2003.03208.x. PMID: 12756036.
* Carey JJ. What is a 'failure' of bisphosphonate therapy for osteoporosis? Cleve Clin J Med. 2005 Nov;72(11):1033-9. doi: 10.3949/ccjm.72.11.1033. PMID: 16315442.
* Jacobs JJ, Hallab NJ, Urban RM, Wimmer MA. Wear particles. J Bone Joint Surg Am. 2006 Apr;88 Suppl 2:99-102. doi: 10.2106/JBJS.F.00102. PMID: 16595453.
* Tan M. Epilepsy in adults. Aust Fam Physician. 2014 Mar;43(3):100-4. PMID: 24600669.
* Funck-Brentano T, Cohen-Solal M. Subchondral bone and osteoarthritis. Curr Opin Rheumatol. 2015 Jul;27(4):420-6. doi: 10.1097/BOR.0000000000000181. PMID: 26002035.
* Burt LA, Billington EO, Rose MS, Raymond DA, Hanley DA, Boyd SK. Effect of High-Dose Vitamin D Supplementation on Volumetric Bone Density and Bone Strength: A Randomized Clinical Trial. JAMA. 2019 Aug 27;322(8):736-745. doi: 10.1001/jama.2019.11889. PMID: 31454046; PMCID: PMC6714464.
* Langdahl BL. Overview of treatment approaches to osteoporosis. Br J Pharmacol. 2021 May;178(9):1891-1906. doi: 10.1111/bph.15024. 2020 Mar 20. PMID: 32060897.
* Whalen RJ, Adriani M, Ganokroj P, Provencher MT. Open Bone Augmentation Solutions for the Failed Shoulder Stabilization. Clin Sports Med. 2024 Oct;43(4):649-660. doi: 10.1016/j.csm.2024.03.022. 2024 Apr 27. PMID: 39232572.
* Roumpou A, Palermo A, Tournis S, Hasenmajer V, Pasieka JL, Kaltsas G, Isidori A, Kassi E. Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes. Endocr Rev. 2025 Jul 15;46(4):576-620. doi: 10.1210/endrev/bnaf010. PMID: 40177730; PMCID: PMC12259238.
* Adami G, Pollastri F, Fassio A, Montanari F, Piccinelli A, Benini C, Pasetto E, Dartizio C, Gatti D, Rossini M, Viapiana O. Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis. Arthritis Rheumatol. 2026 May;78(5):1176-1183. doi: 10.1002/art.70002. 2026 Feb 22. PMID: 41327832; PMCID: PMC13129633.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.